Enzyme Mechanism Linked to Intervertebral Disc Degeneration
Researchers identified how the enzyme ALKBH5 contributes to cell death and disc deterioration.
Updated on Oct. 29, 2026 in Arthritis
Scientists have discovered that the enzyme ALKBH5 stabilizes mRNA to increase levels of interferon regulatory factor 9, a protein linked to disc degeneration. This process promotes necroptosis in nucleus pulposus cells, which contributes to the breakdown of spinal discs.
Why it matters
Understanding this molecular pathway reveals how disc tissue deteriorates at a cellular level, potentially opening new avenues for treatment. By targeting this mechanism, researchers hope to slow the progression of degenerative disc conditions.
Stimulation by tumour necrosis factor alpha was shown to increase necroptosis in nucleus pulposus cells during the study. Researchers found that this effect is mediated by the increased expression of proteins including receptor-interacting protein kinase 1 and 3.
The players
ALKBH5
This is an enzyme responsible for removing N6-methyladenosine modifications from mRNA.
Interferon regulatory factor 9
This protein acts as a critical regulator that promotes cell necroptosis in nucleus pulposus cells.
The details
The enzyme ALKBH5 functions by removing N6-methyladenosine from interferon regulatory factor 9 mRNA, which stabilizes the transcript and allows for higher protein production. Elevated levels of this factor subsequently activate promoters that drive cell necroptosis through the expression of mixed lineage kinase domain-like proteins.
Timeline
The research findings were published on October 29, 2026.
The Big Picture
This discovery shifts the understanding of degenerative disc disease by highlighting the role of post-transcriptional mRNA modification. It builds upon established research into the N6-methyladenosine-mediated necroptosis pathway by demonstrating how localized protein stabilization directly influences tissue longevity.
This research provides a new theoretical basis for future therapies that may one day prevent or slow disc degeneration. While currently limited to animal models, the identification of this pathway offers a target for potential clinical treatments to manage chronic spinal conditions.
The takeaway
Future treatments for degenerative disc disease may involve therapies that modulate specific enzymes like ALKBH5 to prevent cellular breakdown. These findings emphasize the importance of molecular stability in maintaining healthy tissue as research transitions toward potential clinical applications.
Further reading
Learn more about spinal health and related conditions in our Arthritis section.
Source note: This article includes information reported by Nature.
